Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Pregenerate

We accelerate drug development and personalized medicine for arthritis using disease-on-a-chip model
2019
11-50
Vienna, Wien, Austria
BiotechnologynologyLife ScienceMedical DevicePrecision Medicine

Investment Funding

Last Funding Stage

Convertible Note

Total Funding Amount

130.K

Last Funding Date

07-06-2022

Startup Stage

Seed

Lead Investors

SOSV, RebelBio

Revenue

$1M to $10M

People

Founders